Table 1.
Treatment | PW, mm | LVDD, mm | LVSD, mm | FS, % |
---|---|---|---|---|
Sham | ||||
6 wk | 1.83 ± 0.12 | 8.15 ± 0.22 | 4.80 ± 0.22 | 41.4 ± 3.3 |
12 wk | 1.89 ± 0.11 | 8.32 ± 0.31 | 4.97 ± 0.28 | 44.2 ± 4.9 |
18 wk | 1.93 ± 0.10 | 8.55 ± 0.21 | 5.09 ± 0.25 | 40.1 ± 2.8 |
20 wk | 1.91 ± 0.10 | 8.61 ± 0.24 | 5.01 ± 0.24 | 41.4 ± 2.3 |
LVH | ||||
6 wk | 2.42 ± 0.16* | 7.93 ± 0.18 | 4.11 ± 0.21 | 46.8 ± 2.1* |
12 wk | 2.66 ± 0.14* | 8.44 ± 0.24 | 4.30 ± 0.16 | 48.2 ± 2.0* |
18 wk | 2.60 ± 0.18* | 8.87 ± 0.22* | 5.55 ± 0.13 | 36.4 ± 2.6*† |
20–23 wk | 2.68 ± 0.20* | 9.44 ± 0.28* | 6.36 ± 0.10* | 32.6 ± 1.8*† |
PW, posterior wall thickness during diastole; LVDD, left ventricular diameter during diastole; LVSD, left ventricular systolic diameter during systole; FS, fractional shortening; *, P < 0.05 compared to sham at similar time period; †, P < 0.05 compared to values at 6 wk.